These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 852502)

  • 1. Muscimol antagonizes the ergometrine-induced locomotor activity in nucleus accumbens: evidence for a GABA--dopaminergic interaction.
    Scheel-Krüger J; Cools AR; Honig W
    Eur J Pharmacol; 1977 Apr; 42(3):311-3. PubMed ID: 852502
    [No Abstract]   [Full Text] [Related]  

  • 2. Muscimol a GABA-agonist injected into the nucleus accumbens increases apomorphine stereotypy and decreases the motility.
    Scheel-Krũger J; Cools AR; van Wel PM
    Life Sci; 1977 Dec; 21(11):1697-702. PubMed ID: 563960
    [No Abstract]   [Full Text] [Related]  

  • 3. Rotational behaviour after unilateral intranigral injection of muscimol in rats.
    Oberlander C; Dumont C; Boissier JR
    Eur J Pharmacol; 1977 Jun; 43(4):389-90. PubMed ID: 560304
    [No Abstract]   [Full Text] [Related]  

  • 4. GABA-like properties of flurazepam and baclofen suggested by rotational behaviour following unilateral intranigral injection: a comparison with the GABA agonist muscimol [proceedings].
    Waddington JL
    Br J Pharmacol; 1977 Jun; 60(2):263P-264P. PubMed ID: 18250
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of dopamine receptor stimulants on locomotor activity of rats with electrolytic or 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Woodruff GN; Kelly PH; Elkhawad AO
    Psychopharmacologia; 1976 May; 47(2):195-8. PubMed ID: 1273217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of muscimol, a GABA-mimetic agent, on dopamine metabolism in the mouse brain.
    Biggio G; Casu M; Corda MG; Vernaleone F; Gessa GL
    Life Sci; 1977 Aug; 21(4):525-31. PubMed ID: 904431
    [No Abstract]   [Full Text] [Related]  

  • 7. Muscimol differentially facilitates stereotypy but antagonizes motility induced by dopaminergic drugs: a complex GABA-dopamine interaction.
    Scheel-Krüger J; Christensen AV; Arnt J
    Life Sci; 1978 Jan; 22(1):75-84. PubMed ID: 564437
    [No Abstract]   [Full Text] [Related]  

  • 8. GABA-mediated control of rat neostriatal tyrosine hydroxylase revealed by intranigral muscimol.
    Gale KN; Guidotti A
    Nature; 1976 Oct; 263(5579):691-3. PubMed ID: 10528
    [No Abstract]   [Full Text] [Related]  

  • 9. Mesolimbic dopamine and its control of locomotor activity in rats: differences in pharmacology and light/dark periodicity between the olfactory tubercle and the nucleus accumbens.
    Cools AR
    Psychopharmacology (Berl); 1986; 88(4):451-9. PubMed ID: 3085132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central GABA receptor agonists: comparison of muscimol and baclofen.
    Naik SR; Guidotti A; Costa E
    Neuropharmacology; 1976 Aug; 15(8):479-84. PubMed ID: 185540
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavioral correlates of dopaminergic function in the nucleus accumbens.
    van Rossum JM; Broekkamp CL; Pijnenburg AJ
    Adv Biochem Psychopharmacol; 1977; 16():201-7. PubMed ID: 883542
    [No Abstract]   [Full Text] [Related]  

  • 12. Possible GABA-mediated control of dopamine-dependent behavioural effects from the nucleus accumbens of the rat.
    Pycock CJ; Horton RW
    Psychopharmacology (Berl); 1976 Sep; 49(2):173-8. PubMed ID: 825904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscimol antagonizes morphine hypermotility without potentiation of analgesia.
    Christensen AV; Arnt J; Scheel-Krüger J
    Eur J Pharmacol; 1978 Apr; 48(4):459-62. PubMed ID: 648589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for an accumbens-pallidal pathway in the rat and its possible gabaminergic control.
    Pycock C; Horton R
    Brain Res; 1976 Jul; 110(3):629-34. PubMed ID: 947478
    [No Abstract]   [Full Text] [Related]  

  • 15. The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway.
    Olianas MC; De Montis GM; Mulas G; Tagliamonte A
    Eur J Pharmacol; 1978 Jun; 49(3):233-41. PubMed ID: 566207
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulatory effects of baclofen muscimol and GABA on interspecific aggressive behaviour in the rat.
    Delini-Stula A; Vassout A
    Neuropharmacology; 1978 Dec; 17(12):1063-5. PubMed ID: 570649
    [No Abstract]   [Full Text] [Related]  

  • 17. Further investigations on the effects of ergometrine and other ergot derivatives following injection into the nucleus accumbens of the rat.
    Pijnenburg AJ; Honig WM; Boudier HA; Cools AR; Van der Heyden JA; Van Rossum JM
    Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):103-15. PubMed ID: 984962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity studies on the inhibition of GABA binding to rat brain membranes by muscimol and related compounds.
    Krogsgaard-Larsen P; Johnston GA
    J Neurochem; 1978 Jun; 30(6):1377-82. PubMed ID: 670980
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of the GABA receptor agonist muscimol on the turnover of brain dopamine and on the motor activity of rats.
    Andén NE; Grabowska-Andén M; Wachtel H
    Acta Pharmacol Toxicol (Copenh); 1979 Mar; 44(3):191-6. PubMed ID: 433609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical blockade of a muscimol response by THIP, a GABA agonist and also by GABA-transaminase inhibitors.
    Menon MK
    Neuropharmacology; 1981 Dec; 20(12A):1183-6. PubMed ID: 7322293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.